With Continuity of Covid-19 Pandemic, Have Our Anethetic Choices for Caesrean Section Changed ?

August 21, 2022 updated by: Shereen salah

Retrospective Analytic Study Will be Performed to Investigate if There Was a Change in the Choice of Anethetic Technique for Casrean Section With Continuation of Covid-19 Pandemic

This retrospective analytic study will be petformed to investigate if there was a change in the choice of anaethetic technique for caesarean sections with continuation of the COVID-19 pandemic .

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

The number of regional and general anethesia techniques used with detailed number ofspinals epidurals as well as combined spinal epidurals that were provided .

Study Type

Observational

Enrollment (Anticipated)

24

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Dr/omyma Shehata, Associate
  • Phone Number: 01061762894

Study Locations

      • Minya, Egypt
        • Recruiting
        • Minia university
        • Contact:
          • Dr/omyma Shehatta, Associate
        • Contact:
          • Mohamed Glal, Lecturer

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

Number of regional and general anethesia used in covid waves

Description

Inclusion criteria:

  • pregnant women
  • suspected or infected with covid-19
  • women undergo cesarean section .

Exclusion criteria:

  • normal delivery
  • abortion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Spinal anethesia
group number one which recive spinal anethesia in cesarean section in 2020 and 2021
In 2020 and 2021 covid 19 waves in egypt , the effect of this waves in our anathesia in patient wwho undergo cesarean section
General anesthesia
Group number 2 which recive general anathesia in cesarean section in 2020 snd 2021
In 2020 and 2021 covid 19 waves in egypt , the effect of this waves in our anathesia in patient wwho undergo cesarean section

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Type of anethesia
Time Frame: 2020,2021
Number of general and regional anethesia used in pregnant women
2020,2021
Out come of mother
Time Frame: 2 years 2020,2021
Number of cases whose admitted to icu post operative
2 years 2020,2021

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Income of mother
Time Frame: 2020,2021
Numbers of patient whose suspected or infected with covid-19
2020,2021

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 24, 2022

Primary Completion (ANTICIPATED)

October 30, 2022

Study Completion (ANTICIPATED)

November 30, 2022

Study Registration Dates

First Submitted

July 24, 2022

First Submitted That Met QC Criteria

August 21, 2022

First Posted (ACTUAL)

August 24, 2022

Study Record Updates

Last Update Posted (ACTUAL)

August 24, 2022

Last Update Submitted That Met QC Criteria

August 21, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COVID-19 Pandemic

Clinical Trials on On the period of covid 19

Subscribe